Health
Sinovac’s COVID-19 vaccine induces quick immune response: study – Reuters
Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had…
SINGAPORE/BEIJING (Reuters) – Sinovac Biotechs experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
…
-
General21 hours agoIran-Israel conflict: Israel strikes Iran’s oil and gas fields, as Tehran warns of ‘more severe’ response
-
General19 hours agoHelp for disabled youths left at the mercy of carers
-
General20 hours agoAnthony Albanese to meet Donald Trump at G7 talks in Canada
-
General17 hours agoWingham still relying on temporary water solution after Mid North Coast floods